Therapeutic options for pulmonary heart disease combined with heart failure

The treatment plan for pulmonary heart disease combined with heart failure is aggressive infection control, control of respiratory failure, control of heart failure and symptomatic supportive therapy. Pulmonary heart disease refers to pulmonary heart disease, lesions lead to increased pulmonary artery vascular resistance, the formation of pulmonary hypertension, resulting in structural and functional changes in the right ventricle. It can cause respiratory failure and right heart failure, manifested by symptoms such as coughing, coughing up sputum, dyspnea, shortness of breath, palpitations (accelerated heartbeat, often accompanied by panic), decreased appetite, and edema. Respiratory infections are a common cause of exacerbation of pulmonary heart disease and heart failure, and can be treated with cephalosporin and penicillin antibiotics for anti-infection. Symptomatic treatments such as bronchodilators (aminophylline), expectorant (ambroxol), and oxygenation are given to improve respiratory failure. Diuretics (furosemide), positive inotropic agents (digitalis drugs), and vasodilators (nitrates) are used to control heart failure. Heart failure combined with pulmonary heart disease requires timely medical treatment, and the use of drugs and other medications should be under the guidance of a specialized doctor.